Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 751.00
Ask: 751.20
Change: 0.00 (0.00%)
Spread: 0.20 (0.027%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 755.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on disposal of interest in PT Bank Permata

20 Apr 2020 13:39

RNS Number : 2264K
Standard Chartered PLC
20 April 2020
 

Standard Chartered PLC

Update on disposal of interest in PT Bank Permata Tbk

20 April 2020

Standard Chartered PLC (the Group) announces that its wholly owned subsidiary Standard Chartered Bank (SCB) and its partner PT Astra International Tbk (Astra) have agreed with Bangkok Bank Public Company Limited (the Purchaser) to amend the terms of the agreement announced on 12 December 2019 (the Transaction) to sell their aggregate 89.12% equity interest in PT Bank Permata Tbk (Permata). 

The Purchaser has received approval for the Transaction from its shareholders. Permata's shareholders are expected to approve the acquisition plan at an extraordinary general meeting scheduled for 23 April 2020, at which both SCB and Astra are entitled to vote their respective 44.56% shareholdings. The Transaction remains subject to certain conditions, including necessary approvals from the regulatory authorities in Indonesia. 

The parties to the Transaction have agreed to revise the purchase price from 1.77 to 1.63 times Permata's shareholders' equity as at 31 March 2020, subject to the Transaction closing on or prior to 30 June 2020.

FINANCIAL IMPLICATIONS TO STANDARD CHARTERED OF THE TRANSACTION

The latest estimated consideration payable to SCB in cash is approximately IDR17 trillion (US$1.06 billion) being approximately US$0.3 billion greater than the Group's carrying value. The 18% reduction in estimated proceeds compared to that indicated on 12 December 2019 is attributable to the revised valuation multiple, a reduction in Permata's shareholders' equity due to the adoption of IFRS 9 and the recent depreciation of Indonesian Rupiah against the US Dollar.

The Transaction would generate, on the basis of the Group's financial results for the period ended 31 December 2019, an increase in the Group's Common Equity Tier 1 capital ratio of around 40 basis points, reflecting a reduction in risk-weighted assets of around US$9.1 billion and the deconsolidation of US$0.5 billion minority interest equity (net of regulatory adjustments including goodwill).

The impact of the Transaction will be included in normalised items to determine the Group's performance. As the Transaction is expected to close at a future date, the actual consideration and the actual Common Equity Tier 1 capital impact will be determined at completion. 

Note:

 

In this announcement, the conversions of IDR into US$ have been made at the rate of IDR15,800 to US$1. Such conversions are for reference only and should not be construed as representations that the IDR amount could be converted into United States dollars at that rate.

 

Enquiries to:

Mark Stride, Head of Investor Relations +44 (0) 20 7885 8596

Julie Gibson, Head of Media Relations +44 (0) 20 7885 2434

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAALEADAEEFA
Date   Source Headline
2nd May 20242:25 pmRNSQ1 2024 Pillar 3 Disclosures
2nd May 20242:06 pmRNSPublication of Supplementary Prospectus
2nd May 20247:00 amRNS1st Quarter Results
1st May 20245:40 pmRNSTransaction in Own Shares
1st May 202412:20 pmRNSNotice of Redemption
1st May 202410:03 amRNSTotal Voting Rights
30th Apr 20245:36 pmRNSTransaction in Own Shares
29th Apr 20245:29 pmRNSTransaction in Own Shares
26th Apr 20245:30 pmRNSTransaction in Own Shares
26th Apr 202410:17 amRNSOverseas Regulatory Announcement
25th Apr 20245:50 pmRNSTransaction in Own Shares
24th Apr 20246:25 pmRNSPublication of a Prospectus
24th Apr 20245:19 pmRNSTransaction in Own Shares
23rd Apr 20245:50 pmRNSTransaction in Own Shares
22nd Apr 20245:40 pmRNSTransaction in Own Shares
19th Apr 20245:35 pmRNSTransaction in Own Shares
18th Apr 20245:35 pmRNSTransaction in Own Shares
17th Apr 20245:35 pmRNSTransaction in Own Shares
16th Apr 20245:35 pmRNSTransaction in Own Shares
15th Apr 20246:05 pmRNSTransaction in Own Shares
12th Apr 20244:54 pmRNSTransaction in Own Shares
12th Apr 20242:05 pmRNSNotice to ADR Holders of 6.409% Preference Shares
11th Apr 20245:45 pmRNSTransaction in Own Shares
10th Apr 20245:30 pmRNSTransaction in Own Shares
9th Apr 20246:05 pmRNSTransaction in Own Shares
8th Apr 20245:16 pmRNSTransaction in Own Shares
8th Apr 202411:32 amRNSNotice of AGM 2024 and Notice of Class Meeting
5th Apr 202410:30 amRNSOverseas Regulatory Announcement
4th Apr 20245:30 pmRNSTransaction in Own Shares
3rd Apr 20245:13 pmRNSTransaction in Own Shares
2nd Apr 20245:45 pmRNSTransaction in Own Shares
2nd Apr 202410:54 amRNSTotal Voting Rights
2nd Apr 20249:30 amRNSChanges to presentation of financial information
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.